Ironwood Pharmaceuticals, Inc. Stock price
Equities
IRWD
US46333X1081
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.785 USD | +1.91% | -2.33% | -22.90% |
Financials (USD)
Sales 2024 * | 448M | Sales 2025 * | 494M | Capitalization | 1.35B |
---|---|---|---|---|---|
Net income 2024 * | 106M | Net income 2025 * | 139M | EV / Sales 2024 * | 3.01 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.73 x |
P/E ratio 2024 * |
11.1
x | P/E ratio 2025 * |
9.8
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.92% |
Latest transcript on Ironwood Pharmaceuticals, Inc.
1 day | +3.61% | ||
1 week | -5.38% | ||
Current month | -8.59% | ||
1 month | -43.21% | ||
3 months | -25.11% | ||
6 months | -10.49% | ||
Current year | -24.65% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 66 | 08-12-31 |
Sravan Emany
DFI | Director of Finance/CFO | 46 | 21-12-05 |
Marcel Moulaison
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alexander Denner
BRD | Director/Board Member | 54 | 20-11-08 |
Jay Shepard
BRD | Director/Board Member | 66 | 20-12-02 |
Mark Currie
BRD | Director/Board Member | 69 | 19-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 29 M€ | -0.55% | ||
0.42% | 26 M€ | -0.05% | - | |
0.35% | 907 M€ | +9.14% | - | |
0.20% | 46 M€ | +4.03% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 8.82 | +2.32% | 1 330 815 |
24-03-27 | 8.62 | +3.61% | 3,281,085 |
24-03-26 | 8.32 | -1.07% | 2,963,933 |
24-03-25 | 8.41 | -3.11% | 3,612,818 |
24-03-22 | 8.68 | -3.88% | 3,648,957 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.65% | 1.35B | |
+9.16% | 45.97B | |
+53.97% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |